Funded Tech Companies
Degron Therapeutics
Wondering who provided funding to Degron Therapeutics? Baidu Venture Capital, Cowin Venture Capital and Dyee Capital joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Degron Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
3210 Merryfield Row
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Email Address
Company Background Information
Overview
Degron Therapeutics aims to become a global leader in the discovery and development of a new class of targeted protein degradation therapeutics, small molecule molecular glue degrader (MGD) drugs. Degron has assembled a team of world-class executives and scientific leaders, bringing its scientific excellence to the identification and validation of disease targets, particularly those undruggable by conventional small molecule inhibitors, and novel selective MGD compounds to meet unmet medical needs in all therapeutic areas.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/9/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lily Zou
Chief Scientific Officer
Yong Cang
Company Investors
- Baidu Venture Capital
- Cowin Venture Capital
- Dyee Capital
- Med-Fine Capital (Jing Yu)
- NeuX Capital
- Yuanbio Venture Capital
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs